Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Operating Expenses | 22,026 | 18,920 | 22,244 | 16,322 | 15,494 |
| Operating Income | -22,026 | -18,920 | -22,244 | -16,322 | -15,494 |
| Other Income | 10 | 11 | 12 | 17 | 30 |
| Pre-tax Income | -22,016 | -18,909 | -22,232 | -16,305 | -15,464 |
| Net Income Continuous | -22,016 | -18,909 | -22,232 | -16,305 | -15,464 |
| Net Income | $-22,016 | $-18,909 | $-22,232 | $-16,305 | $-15,464 |
| EPS Basic Total Ops | -0.85 | -0.73 | -0.86 | -0.63 | -0.66 |
| EPS Basic Continuous Ops | -0.85 | -0.73 | -0.86 | -0.63 | -0.66 |
| EPS Diluted Total Ops | -0.85 | -0.73 | -0.86 | -0.63 | -0.66 |
| EPS Diluted Continuous Ops | -0.85 | -0.73 | -0.86 | -0.63 | -0.66 |
| EPS Diluted Before Non-Recurring Items | -0.85 | -0.73 | N/A | N/A | N/A |
| EBITDA(a) | $-21,994 | $-18,897 | $-22,224 | $-16,305 | $-15,471 |